BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32278258)

  • 1. Semantic characterization of adverse outcome pathways.
    Wang RL
    Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
    Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
    ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse outcome pathway (AOP) development I: strategies and principles.
    Villeneuve DL; Crump D; Garcia-Reyero N; Hecker M; Hutchinson TH; LaLone CA; Landesmann B; Lettieri T; Munn S; Nepelska M; Ottinger MA; Vergauwen L; Whelan M
    Toxicol Sci; 2014 Dec; 142(2):312-20. PubMed ID: 25466378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
    Ravichandran J; Karthikeyan BS; Samal A
    Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
    Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
    Front Genet; 2018; 9():661. PubMed ID: 30622555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative data-centric approach to derivation and characterization of an adverse outcome pathway network for cadmium-induced toxicity.
    Sahoo AK; Chivukula N; Ramesh K; Singha J; Marigoudar SR; Sharma KV; Samal A
    Sci Total Environ; 2024 Apr; 920():170968. PubMed ID: 38367714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontology-based semantic mapping of chemical toxicities.
    Wang RL; Edwards S; Ives C
    Toxicology; 2019 Jan; 412():89-100. PubMed ID: 30468866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
    Pittman ME; Edwards SW; Ives C; Mortensen HM
    Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.
    Svingen T; Villeneuve DL; Knapen D; Panagiotou EM; Draskau MK; Damdimopoulou P; O'Brien JM
    Toxicol Sci; 2021 Nov; 184(2):183-190. PubMed ID: 34534351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis.
    Verhoeven A; van Ertvelde J; Boeckmans J; Gatzios A; Jover R; Lindeman B; Lopez-Soop G; Rodrigues RM; Rapisarda A; Sanz-Serrano J; Stinckens M; Sepehri S; Teunis M; Vinken M; Jiang J; Vanhaecke T
    Toxicology; 2024 Jun; 505():153814. PubMed ID: 38677583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps.
    Jaylet T; Coustillet T; Smith NM; Viviani B; Lindeman B; Vergauwen L; Myhre O; Yarar N; Gostner JM; Monfort-Lanzas P; Jornod F; Holbech H; Coumoul X; Sarigiannis DA; Antczak P; Bal-Price A; Fritsche E; Kuchovska E; Stratidakis AK; Barouki R; Kim MJ; Taboureau O; Wojewodzic MW; Knapen D; Audouze K
    Front Toxicol; 2024; 6():1285768. PubMed ID: 38523647
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
    Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content.
    Martens M; Evelo CT; Willighagen EL
    Appl In Vitro Toxicol; 2022 Mar; 8(1):2-13. PubMed ID: 35388368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an adverse outcome pathway network for nephrotoxicity.
    Barnes DA; Firman JW; Belfield SJ; Cronin MTD; Vinken M; Janssen MJ; Masereeuw R
    Arch Toxicol; 2024 Mar; 98(3):929-942. PubMed ID: 38197913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.
    Palermo CM; Foreman JE; Wikoff DS; Lea I
    Curr Res Toxicol; 2021; 2():254-271. PubMed ID: 34401750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge.
    Pollesch NL; Villeneuve DL; O'Brien JM
    Toxicol Sci; 2019 Apr; 168(2):349-364. PubMed ID: 30715536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).
    Tsamou M; Roggen EL
    J Alzheimers Dis Rep; 2022; 6(1):271-296. PubMed ID: 35891639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
    Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
    Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area.
    Huliganga E; Marchetti F; O'Brien JM; Chauhan V; Yauk CL
    Front Toxicol; 2022; 4():827328. PubMed ID: 35573276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
    Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
    ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.